Corrigendum
Cancer Gene Therapy (2007) 14, 873–874; doi:10.1038/sj.cgt.7701084
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer
H Wang, G Yang, T L Timme, T Fujita, K Naruishi, A Frolov, M K Brenner, D Kadmon and T C Thompson
